Trial intelligence / Profile preview

SPF and UVAPF Assay of Coppertone (BAY987517)

NCT02803021Completed

Sponsor
Bayer
Start
Oct 2015
Primary completion
Nov 2015
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoints: Minimal Erythema Dose at 15 months and Minimal Persistent Pigment Darkening Dose at 15 months. Started Oct 2015; status: completed.

02

Drugs

BAY987517
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02803021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02803021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call